Dongsung Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dongsung Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Hanall Biopharma Company Limited
sales of 91.84 billion Korean Won [US$77.79 million]
of which 58%
was Finished Goods),
Wooridul Pharmaceutical Limited
(89.10 billion Korean Won [US$75.47 million]
of which 89%
was Finished Goods Revenues), and
JW Shinyak Corp
(91.78 billion Korean Won [US$77.73 million]
of which 65%
was Merchandise Sales).
Dongsung Pharmaceutical Company Limited reported sales of 91.91 billion Korean Won (US$77.85 million)
December of 2018.
increase of 11.6%
versus 2017, when the company's sales were 82.39 billion Korean Won.
This was the fourth straight year of sales growth at Dongsung Pharmaceutical Company Limited.
Sales of Cosmetics/toilet Preparation Segment saw an increase
that was more than double the company's growth rate: sales were up
109.6% in 2018, from
6.57 billion Korean Won to 13.76 billion Korean Won.